A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants
MS200569_0065
Phase 1 other active
Quick answer
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants for Healthy is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- other
- Status
- active